KR ENEMA 161 MG/ML+59 MG/ML RECTAL SOLUTION (67.5 ML) – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for KR ENEMA 161 MG/ML+59 MG/ML RECTAL SOLUTION (67.5 ML), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: KR ENEMA 161 MG/ML+59 MG/ML RECTAL SOLUTION (67.5 ML)

Manufacturer: ŞİFA KİMYA İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

DISODYUM HIDROJEN FOSFAT
SODYUM DIHIDROJEN FOSFAT 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

KR ENEMA 161 MG/ML+59 MG/ML RECTAL SOLUTION (67.5 ML) is formulated with DISODYUM HIDROJEN FOSFAT
SODYUM DIHIDROJEN FOSFAT, a clinically established agent in medical practice.

  • Mechanism of Action: DISODYUM HIDROJEN FOSFAT
    SODYUM DIHIDROJEN FOSFAT acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to DISODYUM HIDROJEN FOSFAT
    SODYUM DIHIDROJEN FOSFAT     therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name KR ENEMA 161 MG/ML+59 MG/ML RECTAL SOLUTION (67.5 ML)
Barcode (GTIN) 8699544356517
Generic Name DISODYUM HIDROJEN FOSFAT
SODYUM DIHIDROJEN FOSFAT
License Holder ŞİFA KİMYA İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ
Pharmacy Retail Price 104.49 TL
⚠️ Clinical Safety Warning

Do not administer KR ENEMA 161 MG/ML+59 MG/ML RECTAL SOLUTION (67.5 ML) if the patient has a known hypersensitivity or allergy to DISODYUM HIDROJEN FOSFAT
SODYUM DIHIDROJEN FOSFAT. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via ŞİFA KİMYA İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ.

Leave a Comment